370 related articles for article (PubMed ID: 35219587)
1. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy.
Ebrahimi N; Adelian S; Shakerian S; Afshinpour M; Chaleshtori SR; Rostami N; Rezaei-Tazangi F; Beiranvand S; Hamblin MR; Aref AR
Cytokine Growth Factor Rev; 2022 Apr; 64():33-45. PubMed ID: 35219587
[TBL] [Abstract][Full Text] [Related]
2. Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance.
Ren Y; Mao X; Xu H; Dang Q; Weng S; Zhang Y; Chen S; Liu S; Ba Y; Zhou Z; Han X; Liu Z; Zhang G
Cell Mol Life Sci; 2023 Aug; 80(9):263. PubMed ID: 37598126
[TBL] [Abstract][Full Text] [Related]
3. Advances in the relationship between ferroptosis and epithelial-mesenchymal transition in cancer.
Mu W; Zhou Z; Shao L; Wang Q; Feng W; Tang Y; He Y; Wang Y
Front Oncol; 2023; 13():1257985. PubMed ID: 38023171
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer.
Lee J; You JH; Kim MS; Roh JL
Redox Biol; 2020 Oct; 37():101697. PubMed ID: 32896720
[TBL] [Abstract][Full Text] [Related]
5. The transcription factor BACH1 at the crossroads of cancer biology: From epithelial-mesenchymal transition to ferroptosis.
Igarashi K; Nishizawa H; Saiki Y; Matsumoto M
J Biol Chem; 2021 Sep; 297(3):101032. PubMed ID: 34339740
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis in Cancer Progression.
Zhang R; Chen J; Wang S; Zhang W; Zheng Q; Cai R
Cells; 2023 Jul; 12(14):. PubMed ID: 37508485
[TBL] [Abstract][Full Text] [Related]
7. HDAC inhibition induces EMT and alterations in cellular iron homeostasis to augment ferroptosis sensitivity in SW13 cells.
Oliveira T; Hermann E; Lin D; Chowanadisai W; Hull E; Montgomery M
Redox Biol; 2021 Nov; 47():102149. PubMed ID: 34600336
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay.
Zhang H; Chen N; Ding C; Zhang H; Liu D; Liu S
Front Oncol; 2024; 14():1344290. PubMed ID: 38469234
[TBL] [Abstract][Full Text] [Related]
9. Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition.
Wang M; Li S; Wang Y; Cheng H; Su J; Li Q
Toxicol Appl Pharmacol; 2020 Aug; 401():115110. PubMed ID: 32533954
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial membrane anchored photosensitive nano-device for lipid hydroperoxides burst and inducing ferroptosis to surmount therapy-resistant cancer.
Sang M; Luo R; Bai Y; Dou J; Zhang Z; Liu F; Feng F; Xu J; Liu W
Theranostics; 2019; 9(21):6209-6223. PubMed ID: 31534546
[No Abstract] [Full Text] [Related]
11. Epithelial-mesenchymal plasticity: Implications for ferroptosis vulnerability and cancer therapy.
Lee J; Roh JL
Crit Rev Oncol Hematol; 2023 May; 185():103964. PubMed ID: 36931615
[TBL] [Abstract][Full Text] [Related]
12. NF-
Zhou Y; Qian W; Li X; Wei W
Oxid Med Cell Longev; 2023; 2023():7098313. PubMed ID: 36699318
[TBL] [Abstract][Full Text] [Related]
13. Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer.
Liu X; Zhang Y; Wu X; Xu F; Ma H; Wu M; Xia Y
Front Pharmacol; 2022; 13():909821. PubMed ID: 35847022
[TBL] [Abstract][Full Text] [Related]
14. Lipid Peroxidation, GSH Depletion, and
Sun L; Dong H; Zhang W; Wang N; Ni N; Bai X; Liu N
DNA Cell Biol; 2021 Feb; 40(2):172-183. PubMed ID: 33351681
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
16. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
[No Abstract] [Full Text] [Related]
17. Broadening horizons: the role of ferroptosis in cancer.
Chen X; Kang R; Kroemer G; Tang D
Nat Rev Clin Oncol; 2021 May; 18(5):280-296. PubMed ID: 33514910
[TBL] [Abstract][Full Text] [Related]
18. Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis.
Jinesh GG; Brohl AS
Signal Transduct Target Ther; 2022 Aug; 7(1):296. PubMed ID: 35999218
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).
Cho ES; Kang HE; Kim NH; Yook JI
Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699
[TBL] [Abstract][Full Text] [Related]
20. Ras promotes transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cells.
Kim H; Choi JA; Kim JH
J Biol Chem; 2014 Aug; 289(32):22151-60. PubMed ID: 24990945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
